163 related articles for article (PubMed ID: 9493699)
1. Evaluation of the efficacy and tolerability of a low-dose combination of isradipine and spirapril in the first-line treatment of mild to moderate essential hypertension.
Pittrow DB; Antlsperger A; Welzel D; Wambach G; Schardt W; Weidinger G
Cardiovasc Drugs Ther; 1997 Nov; 11(5):619-27. PubMed ID: 9493699
[TBL] [Abstract][Full Text] [Related]
2. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
[TBL] [Abstract][Full Text] [Related]
3. Low-dose reserpine/thiazide combination in first-line treatment of hypertension: efficacy and safety compared to an ACE inhibitor.
Griebenow R; Pittrow DB; Weidinger G; Mueller E; Mutschler E; Welzel D
Blood Press; 1997 Sep; 6(5):299-306. PubMed ID: 9360001
[TBL] [Abstract][Full Text] [Related]
4. Acute and chronic effects of spirapril, alone or in combination with isradipine on kidney function and blood pressure in patients with reduced kidney function and hypertension.
Shohat J; Wittenberg C; Erman A; Rosenfeld J; Boner G
Scand J Urol Nephrol; 1999 Feb; 33(1):57-62. PubMed ID: 10100366
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of slow-release oral isradipine in moderate-to-severe hypertension with add-on spirapril.
Abarquez RF; Sy RG; Castillo RR
Am J Hypertens; 1993 Mar; 6(3 Pt 2):77S-79S. PubMed ID: 8466734
[TBL] [Abstract][Full Text] [Related]
6. The effects of isradipine and spirapril as monotherapy and combined therapy on blood pressure, renal hemodynamics, natriuresis, and urinary kallikrein in hypertensive nephropathy.
Maccariello ER; Genelhu de Abreu Fagundes V; Francischetti EA
Am J Hypertens; 1997 May; 10(5 Pt 1):541-5. PubMed ID: 9160765
[TBL] [Abstract][Full Text] [Related]
7. 24-hour ambulatory blood pressure monitoring and spirapril in mild to severe essential hypertension: a randomized dose comparison.
Vreugdenhil G; van Montfrans GA; Jacobs MC; de Bruijn JH; Veerman DP; van Es PN; Mellein B; Guitard C; Thien T; de Leeuw PW
Blood Press Suppl; 1994; 2():23-30. PubMed ID: 8061842
[TBL] [Abstract][Full Text] [Related]
8. Influence of race and dietary salt on the antihypertensive efficacy of an angiotensin-converting enzyme inhibitor or a calcium channel antagonist in salt-sensitive hypertensives.
Weir MR; Chrysant SG; McCarron DA; Canossa-Terris M; Cohen JD; Gunter PA; Lewin AJ; Mennella RF; Kirkegaard LW; Hamilton JH; Weinberger MH; Weder AB
Hypertension; 1998 May; 31(5):1088-96. PubMed ID: 9576119
[TBL] [Abstract][Full Text] [Related]
9. A comparison of spirapril and isradipine in patients with diabetic nephropathy and hypertension.
Nørgaard K; Jensen T; Christensen P; Feldt-Rasmussen B
Blood Press; 1993 Dec; 2(4):301-8. PubMed ID: 8173700
[TBL] [Abstract][Full Text] [Related]
10. A multicentre multidose study of the efficacy and safety of spirapril in mild-to-moderate essential hypertension. UK Study Group of Spirapril in Hypertension.
Fairhurst GJ
Blood Press Suppl; 1994; 2():77-80. PubMed ID: 8061852
[TBL] [Abstract][Full Text] [Related]
11. Comparison of spirapril, isradipine, or combination in hypertensive patients with left ventricular hypertrophy: effects on LVH regression and arrhythmogenic propensity.
Manolis AJ; Beldekos D; Handanis S; Haralabidis G; Hatzissavas J; Foussas S; Cokkinos DV; Bresnahan M; Gavras I; Gavras H
Am J Hypertens; 1998 Jun; 11(6 Pt 1):640-8. PubMed ID: 9657622
[TBL] [Abstract][Full Text] [Related]
12. Single daily administration of spirapril in the treatment of essential hypertension. A multicentre double-blind comparison of 1, 6, 12 and 24 mg of spirapril once daily.
Hayduk K; Schardt F; Sierakowski B; Weidinger G; Welzel D
Blood Press Suppl; 1994; 2():41-6. PubMed ID: 8061845
[TBL] [Abstract][Full Text] [Related]
13. Placebo-controlled comparison of spirapril at 6, 12 and 24 mg/day in mild to severe essential hypertension.
Guitard C; Alvisi V; Maibach E; Franck J; Cocco G; Boxho G; Mellein B; Waite R
Blood Press Suppl; 1994; 2():81-7. PubMed ID: 8061853
[TBL] [Abstract][Full Text] [Related]
14. Partial escape of angiotensin converting enzyme (ACE) inhibition during prolonged ACE inhibitor treatment: does it exist and does it affect the antihypertensive response?
van den Meiracker AH; Man in 't Veld AJ; Admiraal PJ; Ritsema van Eck HJ; Boomsma F; Derkx FH; Schalekamp MA
J Hypertens; 1992 Aug; 10(8):803-12. PubMed ID: 1325513
[TBL] [Abstract][Full Text] [Related]
15. Comparison of efficacy of spirapril and enalapril in control of mild-to-moderate hypertension.
Guitard C; Lohmann FW; Alfiero R; Ruina M; Alvisi V
Cardiovasc Drugs Ther; 1997 Jul; 11(3):449-57. PubMed ID: 9310273
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of spirapril, a new ace-inhibitor, in elderly hypertensive patients.
Kantola I; Terént A; Honkanen T; Järveläinen V; Ekman K; Kataja M
Eur J Clin Pharmacol; 1996; 50(3):155-9. PubMed ID: 8737752
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of blood pressure response to the combination of enalapril (single dose) and diltiazem ER (four different doses) in systemic hypertension.
Applegate WB; Cohen JD; Wolfson P; Davis A; Green S
Am J Cardiol; 1996 Jul; 78(1):51-5. PubMed ID: 8712118
[TBL] [Abstract][Full Text] [Related]
18. Little effect of ordinary antihypertensive therapy on nocturnal high blood pressure in patients with sleep disordered breathing.
Pelttari LH; Hietanen EK; Salo TT; Kataja MJ; Kantola IM
Am J Hypertens; 1998 Mar; 11(3 Pt 1):272-9. PubMed ID: 9544866
[TBL] [Abstract][Full Text] [Related]
19. Nitrendipine and enalapril combination therapy in mild to moderate hypertension: assessment of dose-response relationship by a clinical trial of factorial design.
Roca-Cusachs A; Torres F; Horas M; Ríos J; Calvo G; Delgadillo J; Terán M;
J Cardiovasc Pharmacol; 2001 Dec; 38(6):840-9. PubMed ID: 11707687
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
Mugellini A; Dobovisek J; Planinc D; Cremonesi G; Fogari R
Clin Ther; 2004 Sep; 26(9):1419-26. PubMed ID: 15531004
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]